EDITAS MEDICINE IN revenue breakdown overview

EDITAS MEDICINE IN revenue for the last year amounted to 65.77 M CHF, the most of which — 65.77 M CHF — came from its highest performing source at the moment, Genome Editing Technology, the year earlier bringing 18.23 M CHF. The greatest contribution to the revenue figure was made by United States — last year it brought EDITAS MEDICINE IN 65.77 M CHF, and the year before that — 18.23 M CHF.